A. M. Naik, Madhusudan Kela invest in med-tech firm S3VMutual FundA. M. Naik, Madhusudan Kela invest in med-tech firm S3V

A. M. Naik, Madhusudan Kela invest in med-tech firm S3V


L&T Group chairman emeritus A. M. Naik, investor Madhusudan Kela and other high net worth individuals have invested in Mysore-based medical devices firm S3V Vascular Technologies Ltd, to fund a US-FDA approved manufacturing plant which will make next-generation neurovascular medical devices, said founder and chief executive Badari Narayan, S3V Vascular Technologies.

The company has raised ‘a little less than 300 crore’ in this round, sufficient to complete the project, Narayan said. The proceeds will help the company focus on sales, marketing, manufacturing and securing a US-FDA approval for its manufacturing plant. 

The pre-revenue target company started in 2013 and was first incubated in the Indian School of Business. It has so far focussed on building its technology, but will now focus on generating sales, Narayan said. 

The primary focus of S3V is to build devices to combat the rise of strokes in India, the company said. 

S3V is preparing to launch mechanical thrombectomy devices that can intravenously target and dissolve blood clots, Narayan added. Current devices cost well over 5 lakh while S3V promises to manufacture and sell devices that are around 75,000, making it affordable to a wider population. 

Post the fundraise, the Narayan family will own around 50% stake in the company. Previous investors in S3V include Jito Angels and Laurus Labs founder Satya Chava. 

“S3V is investing in NextGen devices in neuro, cardiac, and spine, creating significant value for customers and contributing to the future of healthcare. Our innovations align seamlessly with Prime Minister Narendra Modi’s Ayushman Bharat (health insurance) programme, affordable healthcare and medico-engineering excellence,” Narayan said in a statement. 

Narayan added that nearly 90% of medical devices in India are imported which presents an opportunity for the market. The Indian medical devices market to reach $50 billion by 2025, Narayan said in the statement. 

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it’s all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Finplay.
Download Finplay News App to get Daily Market Updates & Live Business News.

More
Less

Published: 14 Mar 2024, 05:32 PM IST

Disclaimer: Along with publishing our own news, we get news from various sources namely from news wires ANI, PTI, other reputed finance portals and individual journalists. We are not legally liable for any inaccuracies in the news and expect the reader to do their own due diligence.

http://ganesh@finplay.in

Finance enthusiast, Mutual fund expert.




Leave a Reply

Your email address will not be published. Required fields are marked *

Finplay

AMFI-registered Mutual Fund Distributor ARN-192179

Company

© 2024 Finplay Technologies Private Limited. All Rights Reserved.